Neuroimaging and Physiological Evidence for Involvement of Glutamatergic Transmission in Regulation of the Striatal Dopaminergic System

Aberrant neurotransmissions via glutamate and dopamine receptors have been the focus of biomedical research on the molecular basis of psychiatric disorders, but the mode of their interaction is yet to be uncovered. In this study, we demonstrated the pharmacological reversal of methamphetamine-stimul...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of neuroscience Vol. 29; no. 6; pp. 1887 - 1896
Main Authors Tokunaga, Masaki, Seneca, Nicholas, Shin, Ryong-Moon, Maeda, Jun, Obayashi, Shigeru, Okauchi, Takashi, Nagai, Yuji, Zhang, Ming-Rong, Nakao, Ryuji, Ito, Hiroshi, Innis, Robert B, Halldin, Christer, Suzuki, Kazutoshi, Higuchi, Makoto, Suhara, Tetsuya
Format Journal Article
LanguageEnglish
Published United States Soc Neuroscience 11.02.2009
Society for Neuroscience
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aberrant neurotransmissions via glutamate and dopamine receptors have been the focus of biomedical research on the molecular basis of psychiatric disorders, but the mode of their interaction is yet to be uncovered. In this study, we demonstrated the pharmacological reversal of methamphetamine-stimulated dopaminergic overflow by suppression of group I metabotropic glutamate (mGlu) receptor in living primates and rodents. In viv o positron emission tomography (PET) was conducted on cynomolgus monkeys and rats using a full agonistic tracer for dopamine D 2/3 receptor, [ 11 C]MNPA [( R )-2- 11 CH 3 O- N -n-propylnorapomorphine], and fluctuation of kinetic data resulting from anesthesia was avoided by scanning awake subjects. Excessive release of dopamine induced by methamphetamine and abolishment of this alteration by treatment with an antagonist of group I mGlu receptors, 2-methyl-6-(phenylethynyl)pyridine (MPEP), were measured in both species as decreased binding potential because of increased dopamine and its recovery to baseline levels, respectively. Counteraction of MPEP to the methamphetamine-induced dopamine spillover was also supported neurochemically by microdialysis of unanesthetized rat striatum. Moreover, patch-clamp electrophysiological assays using acute brain slices prepared from rats indicated that direct targets of MPEP mechanistically involved in the effects of methamphetamine are present locally within the striatum. Because MPEP alone did not markedly alter the baseline dopaminergic neurotransmission according to our PET and electrophysiological data, the present findings collectively extend the insights on dopamine–glutamate cross talk from extrastriatal localization of responsible mGlu receptors to intrastriatal synergy and support therapeutic interventions in case of disordered striatal dopaminergic status using group I mGlu receptor antagonists assessable by in vivo imaging techniques.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0270-6474
1529-2401
1529-2401
DOI:10.1523/JNEUROSCI.2559-08.2009